Merck blood clot drug in limbo after mixed results - Yahoo! News

Links shared publicly online about this topic.

  • 0
    total visits

Merck blood clot drug in limbo after mixed results - Yahoo! News

news.yahoo.com

From Yahoo! News: CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, researchers said on Saturday, raising questions whether the company will seek approval of the drug and whether it can pass muster with regulators. Vorapaxar has been dogged by bleeding concerns since January 2011, when a safety committee overseeing the 26,449-patient study said the new type o

View full resource at news.yahoo.com

Tags: Bleeding, Thrombotic Event, Blood Clot, Drug, Merck & Co., News

  • Share

Most Recently Shared on March 24, 2012 at 3:52 pm By:

Doctorwisdom2 OrganizedWisdom

Merck blood clot drug in limbo after mixed results: CHICAGO (Reuters) - Impressive efficacy but worrisome bleedi... http://t.co/V3CP4aUx

2 months ago...

Merck blood clot drug in limbo after mixed results - chicagotribune.com

healthcare.tweetmeme.com — “All the news on healthcareView full resource at healthcare.tweetmeme.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 8:41 pm By:

Merck blood clot drug in limbo after mixed results - chicagotribune.com

chicagotribune.com — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questions whether the company will seek approval of the drug and whether it can pass muster with regulators, researchers said on Saturday.View full resource at chicagotribune.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 7:25 pm By:

tomheston Tom Heston, MD Doctor, Family Medicine Doctor, and Physician

Merck blood clot drug in limbo after mixed results - Chicago Tribune http://t.co/WRT7sDEK #health

2 months ago...

Merck blood clot drug in limbo after mixed results

health.yahoo.net — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, researchers said on Saturday, raising questions whether the company will seek approval of the drug and whether.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 3:40 pm By:

HealthSociety Healthy Society Health News

Merck blood clot drug in limbo after mixed results http://t.co/UqbEmDsV

2 months ago...

Merck blood clot drug in limbo after mixed results | Reuters

reuters.com — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questionsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 2:30 pm By:

HealthNews2 Health News Health News

Merck blood clot drug in limbo after mixed results: CHICAGO (Reuters) - Impressive efficacy but wo... http://t.co/D7llHBd9 #health #news

2 months ago...

Merck blood clot drug in limbo after mixed results

health.yahoo.net — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, researchers said on Saturday, raising questions whether the company will seek approval of the drug and whether.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 2:17 pm By:

JennyBizRN Jennifer Ann Grisso Nurse and Active Health Library

Merck blood clot drug in limbo after mixed results: CHICAGO (Reuters) - Impressive efficacy but worrisome bleedi... http://t.co/pkTWsOfU

2 months ago...

Merck blood clot drug in limbo after mixed results

health.yahoo.net — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questions whether the company will seek approval of the drug and whether it can pass muster with regul.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 2:03 pm By:

Merck blood clot drug in limbo after mixed results | Reuters

reuters.com — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, researchersView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 2:01 pm By:

HealthPassion HealthPassion Health News

Merck blood clot drug in limbo after mixed results: CHICAGO (Reuters) - Impressive efficacy but worrisome bleedi... http://t.co/89kZJOwi

2 months ago...

Merck blood clot drug in limbo after mixed results | Reuters

reuters.com — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questionsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 1:41 pm By:

Merck blood clot drug in limbo after mixed results | Reuters

reuters.com — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questionsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 1:39 pm By:

Reuters_Health Reuters Health Health News

Merck blood clot drug in limbo after mixed results http://t.co/PRRIPy07

2 months ago...

Merck blood clot drug in limbo after mixed results | Reuters

reuters.com — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questionsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 1:38 pm By:

MedicalNews Medical News Health News

Merck blood clot drug in limbo after mixed results http://t.co/ER6kLZ6C

2 months ago...

Advertisement